Transplant recipients often receive treatment for cytomegalovirus, or CMV, prophylactically in the hospital before their organ transplants, as MedicineNet.com explains. Newborns with weakened immune systems may also be treated in the hospital, especially if the CMV is infecting their central nervous systems.
Healthy people generally do not need any treatment for CMV and are unlikely even to be aware that they are carrying the virus, points out Mayo Clinic. Those who do need treatment generally receive antiviral drugs such as ganciclovir, valganciclovir, foscarnet or cidofovir. Ganciclovir is usually the first choice for treatment, with the other antivirals tried only of ganciclovir fails. The drugs are administered intravenously and can have severe side effects, states MedicineNet.com.